In August, 2010 Apredica acquired the intellectual property for offering the
Cellular Systems Biology (CSB™) and High Content Toxicology services developed and commercialized by Cellumen, Inc. Read more.
Why Apredica for Preclinical ADME Tox?
Trusted for Quality
In 2009 Apredica did 265 customer studies. 81% of our business was from repeat customers. 29% of our new customers came from referrals. More about our clients.
Scientist-to-Scientist Communications
All accounts are served by Scientist Study Managers working in the lab on your ADME Tox research.
Fast Turnaround
ADME Tox results in just days. Courier pickup in Cambridge and greater Boston.
Service-Focused CRO - No Internal Drug-Discovery Program
The only drug-discovery programs Apredica advances are those of our clients.
Drug-Discovery Expertise - High Ph.D. Ratio
Apredica's scientists each have more than 10 years' drug-discovery experience. 80% have Ph.D.s. This allows us to customize work to fit clients' needs.
Contact us to discuss how Apredica's
ADME Tox testing services can help your organization
increase the speed of drug discovery while reducing costs. Ask about Apredica's ADDMEsm approach
for Avoiding Drug Development Mistakes Early.